| ID | Name | CAS | Properties |
MW (g/mol) |
| 97-208-4 |
7,11b-Dihydro-6H-indeno[2,1-c]chromene-3,4,6a,9,10-pentol pentakis(trimethylsilyl) ether
|
|
2 | 663.18 |
| 97-220-0 |
Lup-20(29)-en-28-al, 3-(trimethylsilyl)oxy, (3«beta»)-
|
|
2 | 512.88 |
| 97-222-8 |
5-Pregnen-3«beta»,17«alpha»,20«alpha»-triol, (VDMS)3
|
|
2 | 587.07 |
| 97-223-7 |
2-(P-nonylphenoxy)-3-(n-pentyl)-6-(5-nonyl) pyrazine
|
116402-98-3 |
2 | 494.79 |
| 97-230-9 |
3-«alpha»,7-«alpha»,12-«alpha»-Trihydroxy-nor-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 625.11 |
| 97-257-0 |
2-(2,2-Dimethylpentoxy)-3-(n-pentyl)-6-(n-heptyl) pyrazine
|
3049-56-7 |
2 | 362.59 |
| 97-437-0 |
Silane, dimethyl(dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)silyloxy)propoxy-
|
|
2 | 356.65 |
| 97-572-0 |
N-(2-Hydroxy-2-phenyl-ethyl)-4-methyl-benzenesulfonamide, trimethylsilyl ether
|
|
2 | 363.55 |
| 97-709-8 |
Benzenebutanoic acid, «gamma»-oxo-«alpha»,2-bis[(trimethylsilyl)amino]-, trimethylsilyl ester
|
72088-03-0 |
2 | 424.76 |
| 97-833-0 |
3-Benzofuran carboxamide, n-(n-butyl)-2,3-dihydro-3-phenyl-
|
94310-89-1 |
2 | 295.38 |
| 98-172-3 |
10-Methoxy-14-methyl-5-oxo-5,7,8,14-tetrahydro-indolo-[2,3-c]-quinazo-[3,2,a]-pyridine
|
|
2 | 331.37 |
| 98-185-9 |
Xanthurenic acid, O,O'-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 547.95 |
| 98-195-8 |
Silane, [(3-heptyl-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-yl)oxy]dimethyl-2-propenyl-, (6aR-trans)-
|
66250-91-7 |
2 | 440.73 |
| 98-389-3 |
3-Amino-1-methyl-5-methylthio-1,2,4-triazole
|
|
2 | 144.20 |
| 98-438-8 |
S-triazolo[2,3-c]pyrimidin-2(3h)-one, 8-amino-7-chloro-
|
15129-01-8 |
2 | 185.57 |
| 98-806-9 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-(2-chloroethoxy)
|
|
2 | 360.21 |
| 98-960-8 |
3-Oxo-7«alpha»-hydroxy-4-cholenic acid, methyl ester, TMS
|
|
2 | 546.93 |
| 99-219-0 |
12-«alpha»-Hydroxy-9,15-cyclo-GA9, methyl ester, TMS
|
|
2 | 416.58 |
| 99-220-8 |
12-«alpha»-Hydroxy-9,15-cyclo-GA9, methyl ester [D2], TMS
|
|
2 | 416.58 |
| 99-221-7 |
11-«alpha»-Hydroxy-9,15-cyclo-GA9, methyl ester [D2], TMS
|
|
2 | 416.58 |
| 99-317-1 |
Benzoic acid, 2-hydroxy-6-methyl-3-(1-methylethyl), DTBS
|
|
2 | 334.53 |
| 99-318-0 |
Trimethylsilyl 3-(3-chloro-4-[(trimethylsilyl)oxy]phenyl)-2-[(trimethylsilyl)amino]propanoate
|
|
2 | 432.18 |
| 99-370-2 |
Copper, bis(2,6-dimethyl-3,5-heptanedionato-O,O')-, (sp-4-1)-
|
17653-77-9 |
2 | 373.97 |
| 102-894-6 |
2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane
|
|
2 | 468.54 |
| 107-025-5 |
Silane, trimethoxy[2-(7-oxabicyclo[4.1.0]hept-3-yl)ethyl]-
|
3388-04-3 |
2 | 246.38 |
| 112-595-7 |
Isoxazolium compounds: 2-ethyl-5-(m-sulfophenyl)-hydroxide, inner salt
|
|
2 | 253.27 |
| 112-617-2 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, MO TMS #1
|
|
2 | 612.08 |
| 112-629-9 |
4-Pentenoic acid, 2-(1-oxopropyl), enol-bis-TMS, # 1
|
|
2 | 300.55 |
| 112-665-9 |
l-Histidine, 1-(tert-butyldimethylsilyl)-N-methyl-, tert-butyldimethylsilyl ester
|
|
2 | 397.70 |
| 112-740-5 |
5-«beta»-Cholestan-3-«alpha»,7-«alpha»,12-«alpha»,25,26-pentol, TMS
|
|
2 | 813.57 |
| 112-863-9 |
2,2,4,6-tetramethyl-4,6-diphenyl-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 346.61 |
| 112-924-1 |
1H-naphth[1,2-d]imidazole, 1-(p-anisidino)-2-(p-methoxyphenyl)-
|
|
2 | 395.46 |
| 112-952-0 |
N,n'-diacetyl-n,n'-bis-[5-benzylmercapto-1,3,4-thiadiazolyl-2-]hydrazine
|
|
2 | 528.71 |
| 112-993-5 |
15(S)-15-Methyl-PGD2, EO-TMS, isomer # 1
|
|
2 | 626.10 |
| 113-027-6 |
Prosta-10,13-dien-1-oic acid, 9-oxo-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (13E,15S)-
|
55429-54-4 |
2 | 480.83 |
| 113-104-0 |
Xylonic acid, 2,3,4-tris-O-(trimethylsilyl)-, .delta.-lactone, D-
|
|
2 | 364.66 |
| 113-128-4 |
2(3H)-Furanone, dihydro-3-[(trimethylsilyl)oxy]-3-[[(trimethylsilyl)oxy]methyl]-
|
|
2 | 276.48 |
| 113-158-1 |
5-P-anisyl-7-oxo-1,2,3a,4-tetrazaindene
|
|
2 | 242.24 |
| 113-161-7 |
1,3-Propanediol, 2,2-dimethyl-, bis(cyclic 2,2-dimethyltrimethylene phosphite)
|
|
2 | 368.35 |
| 113-166-2 |
1-Cyclohexene-1-carboxylic acid, 3,4,5-tris[(trimethylsilyl)oxy]-, trimethylsilyl ester, [3R-(3«alpha»,4«alpha»,5«beta»)]-
|
55520-78-0 |
2 | 462.88 |
| 113-282-3 |
Oxadiazole, 1,2,4-, 5-(4-butoxyphenyl)-3-(5-nitrofuran-2-yl)-
|
|
2 | 329.31 |
| 113-399-4 |
Carbamic acid, n-methyl, n-nitroso-, 4[2-(n'-methyl-n'-nitroso-ureido)ethyl]phenyl ester
|
|
2 | 309.28 |
| 113-585-7 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)isohexyloxy-
|
|
2 | 464.52 |
| 113-687-4 |
4-Aminobenzoic acid, N- pentafluoropropionyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 511.67 |
| 113-716-1 |
Theanderose: aD-Gclp(1->6)-aDGlcp(1->2)-DFru, oxime-TMS
|
|
2 | 1284.40 |
| 113-796-3 |
9-Oxo-11-octadecenoic acid, 13-hydroxy, PFBO, TMS, methyl ester, # 2
|
|
2 | 593.74 |
| 113-797-2 |
4-Pregnen-3-«beta»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 505.88 |
| 113-823-2 |
Pyrimidine, 6-amino-4-hydroxy-5-(3-carboxypropionyl)amino, TMS
|
|
2 | 442.73 |
| 113-932-1 |
9H-Purine, 9-[2,3-bis-O-(trimethylsilyl)-«beta»-D-ribofuranosyl]-6-(trimethylsiloxy)-2-[(trimethylsilyl)amino]-, 5'-[bis(trimethylsilyl) phospate]
|
32653-15-9 |
2 | 796.31 |
| 113-943-9 |
6-Bromo-3-phenyl-3,4-dihydro-2h-1,3-benzoxazine
|
|
2 | 290.16 |
| 113-980-8 |
D-(-)-Citramalic acid, tert-butyldimethylsilyl ether, bis(tert-butyldimethylsilyl) ester
|
|
2 | 490.90 |
| 114-028-4 |
2,2,4,4,6,8,10-heptamethyl-6,8,10-tri(2-cyanoethyl)-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 487.89 |
| 114-074-3 |
2-Amino-4,6-dihydroxypyrimidine, N-trimethylsilyl-, bis(trimethylsilyl) ether
|
|
2 | 343.65 |
| 114-110-2 |
3'-Glucosyl-isomaltose: aD-Glcp(1->3)-aDGlcp(1->6)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 114-159-9 |
Silane, diphenylisohexyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 475.42 |
| 114-161-6 |
Silane, diphenylhexyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 475.42 |
| 114-328-1 |
Butanoic acid, 2,2-dimethyl-3-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55530-56-8 |
2 | 276.52 |
| 114-347-0 |
1H-Indole-3-acetic acid, 5-methoxy-1-(trimethylsilyl)-, trimethylsilyl ester
|
|
2 | 349.58 |
| 114-351-5 |
Silane, diphenylhexyloxy(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
2 | 514.53 |
| 114-427-1 |
S-triazolo[1,5-a]pyrimidin-7-ol-, 5-phenyl- (keto form)
|
|
2 | 212.21 |
| 114-490-1 |
5«xi»-Pregnan-11-one, 1«xi»,3«xi»,20«xi»-trihydroxy, EO-TMS
|
|
2 | 610.10 |
| 114-542-3 |
13,14-Dihydro-15-keto-PGF1A, EO-TMS, isomer # 1
|
|
2 | 616.11 |
| 114-573-9 |
6'-Galactosyl-lactose: bD-Galp(1->6)-bDGalp(1->4)-DGlu, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 114-581-0 |
3-hydroxy-4-methylglutamic acid, N(O,S)-isoBOC TBDMS, diastreoisomer 1
|
|
2 | 591.88 |
| 114-646-8 |
2,4,6-trimethyl-2,4,6-tri(2-cyanoethyl)-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 339.57 |
| 114-723-2 |
15(S)-15-Methyl-PGA2, BO-TMS, isomer # 1
|
|
2 | 563.97 |
| 114-778-2 |
Methyl 5-.beta.-cholan-3-one-24-oate, oxime, TMS # 2
|
|
2 | 475.79 |
| 114-784-5 |
9H-purine, 2,6-dichloro-9-beta-d-ribofuranosyl-, 2',3',5'-triacetate
|
|
2 | 447.23 |
| 114-859-2 |
Pentanoic acid, 3-oxo-2-propyl, enol-bis-TMS, # 1
|
|
2 | 302.56 |
| 114-951-9 |
2-Propenoic acid, 3-[1-(trimethylsilyl)-1H-indol-3-yl]-, trimethylsilyl ester
|
55124-88-4 |
2 | 331.56 |
| 114-952-8 |
L-Tryptophan, N,1-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 547.01 |
| 114-953-7 |
27-nor-5-«beta»-Cholestan-3-«alpha»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 2
|
|
2 | 829.53 |
| 114-954-6 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,20-O)-diTMTBSi
|
|
2 | 603.08 |
| 114-955-5 |
2,2,4,4,6,8-Hexamethyl-6,8-diphenyl-[1,3 ,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 420.76 |
| 114-956-4 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, EO-TMS
|
|
2 | 450.85 |
| 114-971-7 |
5«beta»-Pregnane-20-one-3«alpha»,21-diol, EO-TMS, # 1
|
|
2 | 507.90 |
| 114-973-5 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)silyloxy)(2,6-dimethylnon-1-en-3-yn-5-yloxy)-
|
|
2 | 462.81 |
| 114-979-9 |
3,20-Dioxo-11«beta»,18-epoxy-17«alpha»,18,21-trihydroxy-4-pregnene, MO-TMS, anti
|
|
2 | 651.07 |
| 115-079-7 |
Cholanic acid, 3.alpha.,6.alpha.,7.alpha.-trihydroxy, Me-DMES
|
|
2 | 681.24 |
| 115-175-0 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprost-13-enoic acid, EO-TMS # 1
|
|
2 | 628.12 |
| 115-211-9 |
Phthalimide, n-[4-(tetrahydro-2-oxo-2h-1,3-oxazin-3-yl)butyl]-
|
23545-36-0 |
2 | 302.33 |
| 115-212-8 |
N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, benzyloxime (isomer 1)
|
|
2 | 615.07 |
| 115-214-6 |
N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, benzyloxime (isomer 2)
|
|
2 | 615.07 |
| 115-339-8 |
3H-1,4-benzodiazepine, 1,2,4,5-tetrahydro- 4-(p-methoxyphenyl)-1-methyl-
|
|
2 | 268.36 |
| 115-364-0 |
4,6-Pteridinediol, 2-trimethylsilamino-, O,O-bis(trimethylsilyl)-, ether
|
|
2 | 395.68 |
| 115-511-6 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)ethoxy-
|
|
2 | 268.47 |
| 115-671-9 |
13,14-Dihydro-15-keto-PGF2A, MO-TMS, isomer # 1
|
|
2 | 600.08 |
| 115-711-4 |
3-Furoic acid, dimethyl(3,3,3-trifluoropropyl)silyl ester
|
|
2 | 266.29 |
| 115-766-4 |
Prosta-5,8(12),13-trien-1-oic acid, 9-(methoxyimino)-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (5Z,13E,15S)-
|
56009-42-8 |
2 | 507.85 |
| 115-789-9 |
Ethylthiosulfuric acid, 2-[(1,7,7-trimethylbicyclo[2.2.1.]hept-2-yl)-amino]-
|
|
2 | 293.45 |
| 115-811-3 |
5«xi»-Pregnan-11-one, 1«xi»,3«xi»,20«xi»-trihydroxy, TMSO-TMS
|
|
2 | 654.23 |
| 115-939-2 |
3'-Glucosyl-isomaltose: aD-Glcp(1->3)-aDGlcp(1->6)-DGlc, oxime-TMS, isomer # 1
|
|
2 | 1385.63 |
| 116-000-2 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, 19-hydroxy, EO-TMS # 1
|
|
2 | 714.28 |
| 116-021-9 |
2,6(Or 5)-pyrazinediol, 3-amino-5(or 6)-methyl-
|
116659-94-0 |
2 | 141.13 |
| 116-022-8 |
N-(beta-cyclohexyl-beta-hydroxy-beta-phenyl-ethyl)-n'-methylpiperazine methosulfate
|
|
2 | 428.59 |
| 116-033-6 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, 19-hydroxy, MO-TMS # 1
|
|
2 | 700.26 |
| 116-104-7 |
Trimethylsilyl 4-(2,2-dimethyl-1-(trimethylsilyl(hydrazino)-4-oxo-butanoate
|
|
2 | 304.54 |
| 116-191-1 |
D-Glucuronic acid, 2,4,5-tris-O-(trimethylsilyl)-, lactone
|
|
2 | 392.67 |
| 116-209-1 |
3-Deoxy-2-C-hydroxymethyl-erythro-pentonic acid, 1,4-lactone, TMS
|
|
2 | 378.68 |
| 116-291-0 |
13,14-Dihydro-6,15-diketo-PGF1A, MO-TMS, isomer # 2
|
|
2 | 645.12 |
|
« Previous Results
Next Results »
|